A citation-based method for searching scientific literature

Lisa M McGinnis, Veronica Ibarra-Lopez, Sandra Rost, James Ziai. J Pathol 2021
Times Cited: 3







List of co-cited articles
2 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


TGF-β Inhibition and Immunotherapy: Checkmate.
Karuna Ganesh, Joan Massagué. Immunity 2018
57
66

Top 10 Challenges in Cancer Immunotherapy.
Priti S Hegde, Daniel S Chen. Immunity 2020
213
66

Emerging biomarkers for neoadjuvant immune checkpoint inhibitors in operable non-small cell lung cancer.
Monika Pradhan, Mathieu Chocry, Don L Gibbons, Boris Sepesi, Tina Cascone. Transl Lung Cancer Res 2021
4
33


TCR repertoire intratumor heterogeneity of CD4+ and CD8+ T cells in centers and margins of localized lung adenocarcinomas.
Chaoting Zhang, Huirong Ding, Hongying Huang, Heyilimu Palashati, Yu Miao, Hongchao Xiong, Zheming Lu. Int J Cancer 2019
17
33

The Value of PD-L1 Expression in Predicting the Efficacy of Anti-PD-1 or Anti-PD-L1 Therapy in Patients with Cancer: A Systematic Review and Meta-Analysis.
Xiao-Jiang Chen, Shu-Qiang Yuan, Jin-Ling Duan, Yong-Ming Chen, Shi Chen, Yun Wang, Yuan-Fang Li. Dis Markers 2020
4
33

Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial.
Thomas Powles, Mark Kockx, Alejo Rodriguez-Vida, Ignacio Duran, Simon J Crabb, Michiel S Van Der Heijden, Bernadett Szabados, Albert Font Pous, Gwenaelle Gravis, Urbano Anido Herranz,[...]. Nat Med 2019
133
33


Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade.
Nicholas McGranahan, Andrew J S Furness, Rachel Rosenthal, Sofie Ramskov, Rikke Lyngaa, Sunil Kumar Saini, Mariam Jamal-Hanjani, Gareth A Wilson, Nicolai J Birkbak, Crispin T Hiley,[...]. Science 2016
33

Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study.
Andrea Necchi, Andrea Anichini, Daniele Raggi, Alberto Briganti, Simona Massa, Roberta Lucianò, Maurizio Colecchia, Patrizia Giannatempo, Roberta Mortarini, Marco Bianchi,[...]. J Clin Oncol 2018
209
33

Infiltrating stromal immune cells in inflammatory breast cancer are associated with an improved outcome and increased PD-L1 expression.
C Van Berckelaer, C Rypens, P van Dam, L Pouillon, M Parizel, K A Schats, M Kockx, W A A Tjalma, P Vermeulen, S van Laere,[...]. Breast Cancer Res 2019
25
33

Biology and therapeutic targeting of tumour-associated macrophages.
Tim Beltraminelli, Michele De Palma. J Pathol 2020
20
33

Clinical and pathologic features associated with PD-L1 (SP142) expression in stromal tumor-infiltrating immune cells of triple-negative breast carcinoma.
Raza Syed Hoda, Edi Brogi, Carlos Henrique Dos Anjos, Anne Grabenstetter, Katia Ventura, Sujata Patil, Pier Selenica, Britta Weigelt, Jorge Sergio Reis-Filho, Tiffany Traina,[...]. Mod Pathol 2020
3
33

Myeloid-derived suppressor cells suppress antitumor immune responses through IDO expression and correlate with lymph node metastasis in patients with breast cancer.
Jinpu Yu, Weijiao Du, Fang Yan, Yue Wang, Hui Li, Shui Cao, Wenwen Yu, Chun Shen, Juntian Liu, Xiubao Ren. J Immunol 2013
318
33

Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy.
Janis M Taube, Alison Klein, Julie R Brahmer, Haiying Xu, Xiaoyu Pan, Jung H Kim, Lieping Chen, Drew M Pardoll, Suzanne L Topalian, Robert A Anders. Clin Cancer Res 2014
33

Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) T cells.
Stefani Spranger, Robbert M Spaapen, Yuanyuan Zha, Jason Williams, Yuru Meng, Thanh T Ha, Thomas F Gajewski. Sci Transl Med 2013
33

Nitric oxide mediated inhibition of antigen presentation from DCs to CD4+ T cells in cancer and measurement of STAT1 nitration.
Joseph Markowitz, Jiang Wang, Zach Vangundy, Jia You, Vedat Yildiz, Lianbo Yu, Isaac P Foote, Owen E Branson, Andrew R Stiff, Taylor R Brooks,[...]. Sci Rep 2017
25
33

Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors.
Thomas Duhen, Rebekka Duhen, Ryan Montler, Jake Moses, Tarsem Moudgil, Noel F de Miranda, Cheri P Goodall, Tiffany C Blair, Bernard A Fox, Jason E McDermott,[...]. Nat Commun 2018
214
33

Density of immunogenic antigens does not explain the presence or absence of the T-cell-inflamed tumor microenvironment in melanoma.
Stefani Spranger, Jason J Luke, Riyue Bao, Yuanyuan Zha, Kyle M Hernandez, Yan Li, Alexander P Gajewski, Jorge Andrade, Thomas F Gajewski. Proc Natl Acad Sci U S A 2016
193
33

Preoperative ipilimumab plus nivolumab in locoregionally advanced urothelial cancer: the NABUCCO trial.
Nick van Dijk, Alberto Gil-Jimenez, Karina Silina, Kees Hendricksen, Laura A Smit, Jeantine M de Feijter, Maurits L van Montfoort, Charlotte van Rooijen, Dennis Peters, Annegien Broeks,[...]. Nat Med 2020
42
33

MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy.
Annelisa M Cornel, Iris L Mimpen, Stefan Nierkens. Cancers (Basel) 2020
19
33

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014.
R Salgado, C Denkert, S Demaria, N Sirtaine, F Klauschen, G Pruneri, S Wienert, G Van den Eynden, F L Baehner, F Penault-Llorca,[...]. Ann Oncol 2015
33

The path to a better biomarker: application of a risk management framework for the implementation of PD-L1 and TILs as immuno-oncology biomarkers in breast cancer clinical trials and daily practice.
Paula I Gonzalez-Ericsson, Elisabeth S Stovgaard, Luz F Sua, Emily Reisenbichler, Zuzana Kos, Jodi M Carter, Stefan Michiels, John Le Quesne, Torsten O Nielsen, Anne-Vibeke Laenkholm,[...]. J Pathol 2020
38
33

The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment.
Vinit Kumar, Sima Patel, Evgenii Tcyganov, Dmitry I Gabrilovich. Trends Immunol 2016
802
33

PD-1/PD-L1 inhibitors.
Joel Sunshine, Janis M Taube. Curr Opin Pharmacol 2015
284
33

Antigen presentation profiling reveals recognition of lymphoma immunoglobulin neoantigens.
Michael S Khodadoust, Niclas Olsson, Lisa E Wagar, Ole A W Haabeth, Binbin Chen, Kavya Swaminathan, Keith Rawson, Chih Long Liu, David Steiner, Peder Lund,[...]. Nature 2017
136
33

PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Paul C Tumeh, Christina L Harview, Jennifer H Yearley, I Peter Shintaku, Emma J M Taylor, Lidia Robert, Bartosz Chmielowski, Marko Spasic, Gina Henry, Voicu Ciobanu,[...]. Nature 2014
33

Dysfunctional CD8 T Cells Form a Proliferative, Dynamically Regulated Compartment within Human Melanoma.
Hanjie Li, Anne M van der Leun, Ido Yofe, Yaniv Lubling, Dikla Gelbard-Solodkin, Alexander C J van Akkooi, Marlous van den Braber, Elisa A Rozeman, John B A G Haanen, Christian U Blank,[...]. Cell 2019
236
33

The European Medicines Agency review of the initial application of atezolizumab and the role of PD-L1 expression as biomarker for checkpoint inhibitors.
I Araujo-Fernandez, J Delgado, L Moscetti, S B Sarac, H Zander, S Mueller-Egert, K Dunder, E Pean, L Bergmann, H Enzmann,[...]. ESMO Open 2021
1
100

HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape.
Francisco Perea, Abel Sánchez-Palencia, Mercedes Gómez-Morales, Mónica Bernal, Ángel Concha, Míguela Méndez García, Amanda Rocío González-Ramírez, Martin Kerick, Javier Martin, Federico Garrido,[...]. Oncotarget 2017
38
33

CD8+ T cell states in human cancer: insights from single-cell analysis.
Anne M van der Leun, Daniela S Thommen, Ton N Schumacher. Nat Rev Cancer 2020
94
33

Neoantigen-directed immune escape in lung cancer evolution.
Rachel Rosenthal, Elizabeth Larose Cadieux, Roberto Salgado, Maise Al Bakir, David A Moore, Crispin T Hiley, Tom Lund, Miljana Tanić, James L Reading, Kroopa Joshi,[...]. Nature 2019
238
33

Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer.
Zuzana Kos, Elvire Roblin, Rim S Kim, Stefan Michiels, Brandon D Gallas, Weijie Chen, Koen K van de Vijver, Shom Goel, Sylvia Adams, Sandra Demaria,[...]. NPJ Breast Cancer 2020
11
33

Cancer-associated fibroblasts connect metastasis-promoting communication in colorectal cancer.
Joke Tommelein, Laurine Verset, Tom Boterberg, Pieter Demetter, Marc Bracke, Olivier De Wever. Front Oncol 2015
97
33

The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker.
Denis L Jardim, Aaron Goodman, Debora de Melo Gagliato, Razelle Kurzrock. Cancer Cell 2021
16
33

Isolation of neoantigen-specific T cells from tumor and peripheral lymphocytes.
Cyrille J Cohen, Jared J Gartner, Miryam Horovitz-Fried, Katerina Shamalov, Kasia Trebska-McGowan, Valery V Bliskovsky, Maria R Parkhurst, Chen Ankri, Todd D Prickett, Jessica S Crystal,[...]. J Clin Invest 2015
215
33

Mechanisms regulating PD-L1 expression on tumor and immune cells.
Shuming Chen, George A Crabill, Theresa S Pritchard, Tracee L McMiller, Ping Wei, Drew M Pardoll, Fan Pan, Suzanne L Topalian. J Immunother Cancer 2019
81
33

Comparability of PD-L1 immunohistochemistry assays for non-small-cell lung cancer: a systematic review.
Bregje M Koomen, Sushil K Badrising, Michel M van den Heuvel, Stefan M Willems. Histopathology 2020
16
33

Dual targeting of TGF-β and PD-L1 via a bifunctional anti-PD-L1/TGF-βRII agent: status of preclinical and clinical advances.
Hanne Lind, Sofia R Gameiro, Caroline Jochems, Renee N Donahue, Julius Strauss, James L Gulley, Claudia Palena, Jeffrey Schlom. J Immunother Cancer 2020
49
33

Acquired Resistance to Immune Checkpoint Inhibitors.
Adam J Schoenfeld, Matthew D Hellmann. Cancer Cell 2020
49
33

Single-cell RNA Sequencing in Immunology.
Yirui Cao, Yue Qiu, Guowei Tu, Cheng Yang. Curr Genomics 2020
2
50

Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer Patient.
Alejandro Jiménez-Sánchez, Danish Memon, Stephane Pourpe, Harini Veeraraghavan, Yanyun Li, Hebert Alberto Vargas, Michael B Gill, Kay J Park, Oliver Zivanovic, Jason Konner,[...]. Cell 2017
217
33

The Promises and Challenges of Tumor Mutation Burden as an Immunotherapy Biomarker: A Perspective from the International Association for the Study of Lung Cancer Pathology Committee.
Lynette M Sholl, Fred R Hirsch, David Hwang, Johan Botling, Fernando Lopez-Rios, Lukas Bubendorf, Mari Mino-Kenudson, Anja C Roden, Mary Beth Beasley, Alain Borczuk,[...]. J Thorac Oncol 2020
35
33

Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer.
Ana Costa, Yann Kieffer, Alix Scholer-Dahirel, Floriane Pelon, Brigitte Bourachot, Melissa Cardon, Philemon Sirven, Ilaria Magagna, Laetitia Fuhrmann, Charles Bernard,[...]. Cancer Cell 2018
384
33

Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab.
David R Gandara, Sarah M Paul, Marcin Kowanetz, Erica Schleifman, Wei Zou, Yan Li, Achim Rittmeyer, Louis Fehrenbacher, Geoff Otto, Christine Malboeuf,[...]. Nat Med 2018
434
33

Regulation of PD-L1 expression in the tumor microenvironment.
Ming Yi, Mengke Niu, Linping Xu, Suxia Luo, Kongming Wu. J Hematol Oncol 2021
16
33

Differential regulation of PD-L1 expression by immune and tumor cells in NSCLC and the response to treatment with atezolizumab (anti-PD-L1).
Marcin Kowanetz, Wei Zou, Scott N Gettinger, Hartmut Koeppen, Mark Kockx, Peter Schmid, Edward E Kadel, Ignacio Wistuba, Jamie Chaft, Naiyer A Rizvi,[...]. Proc Natl Acad Sci U S A 2018
94
33

Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden.
Matthew D Hellmann, Tudor-Eliade Ciuleanu, Adam Pluzanski, Jong Seok Lee, Gregory A Otterson, Clarisse Audigier-Valette, Elisa Minenza, Helena Linardou, Sjaak Burgers, Pamela Salman,[...]. N Engl J Med 2018
33

CD8+ and Regulatory T cells Differentiate Tumor Immune Phenotypes and Predict Survival in Locally Advanced Head and Neck Cancer.
Alessia Echarti, Markus Hecht, Maike Büttner-Herold, Marlen Haderlein, Arndt Hartmann, Rainer Fietkau, Luitpold Distel. Cancers (Basel) 2019
18
33

Transplantation of engineered organoids enables rapid generation of metastatic mouse models of colorectal cancer.
Kevin P O'Rourke, Evangelia Loizou, Geulah Livshits, Emma M Schatoff, Timour Baslan, Eusebio Manchado, Janelle Simon, Paul B Romesser, Benjamin Leach, Teng Han,[...]. Nat Biotechnol 2017
101
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.